Recruiting studies: Localized Pancreatic Adenocarcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Neoadjuvant Triple Therapy for (Borderline) Resectable Pancreatic Cancer (PREOPANC-5)
Phase 1/Phase 2 · 4 location(s) · Amsterdam UMC, location VUmc · NCT06384560 A Brief Psychological Intervention to Improve Emotional Well-Being During Neoadjuvant Therapy for Pancreatic Cancer
NA · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT07124611 Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic Cancer
Phase 2 · 1 location(s) · Loma Linda University · NCT03492671 Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal
Phase 2 · 1 location(s) · Mayo Clinic · NCT05518903 The HELPP Score: A Pretreatment Score to Predict Survival in Pancreatic Cancer
Phase N/A · 1 location(s) · Medical University of Vienna · NCT05752812 In-Depth Characterisation of Biliary Strictures and Hepato-Pancreato-Biliary Focal Lesions for Development of New Techno
Phase N/A · 1 location(s) · University of Nottingham · NCT07206355 NIR-Fluorescence Guided Surgical Resection of Neoadjuvant Treated Localized Pancreatic Cancer Using SGM-101
Phase 2 · 1 location(s) · Leiden University Medical Center · NCT05984810 Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma
Phase 2 · 5 location(s) · Gulam Manji · NCT06048484 Intraoperative Radiation Therapy After Stereotactic Body Radiation Therapy and Chemotherapy in Treatment of Pancreatic A
Phase 1 · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT05141513 Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer
Phase 2 · 3 location(s) · Baylor College of Medicine · NCT05132504 Pancreatic Cancer Adaptive Neoadjuvant Chemotherapy Trial
Phase 2 · 1 location(s) · Medical College of Wisconsin · NCT03322995

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.